Review
Open access
Oct 2026
TMAO at the Crossroads of the Gut–Brain Axis: Emerging Mechanisms Linking Microbiota-Derived Metabolites to Neuroinflammation and Cognitive Dysfunction
The potential use of TMAO and its precursors as therapeutic targets for multiple neurodegenerative disorders is suggested, however, the need for conducting large, adequately powered randomized clinical studies to determine its therapeutic relevance is emphasized.
Aseel Y. Altahrawi, F. Sofi, Zara Kanjwal et al.
· Cells · 0 citations